Medtronic Stock: Is Wall Street Bullish or Bearish?

Galway, Ireland-based Medtronic plc (MDT) develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients. Valued at $116.6 billion by market cap, the company's principal products include those for bradycardia pacing, tachyarrhythmia management, atrial fibrillation management, heart failure management, heart valve replacement, malignant and non-malignant pain, and movement disorders.

Shares of this medical devices giant have underperformed the broader market over the past year. MDT has gained 5.7% over this time frame, while the broader S&P 500 Index ($SPX) has rallied nearly 22.6%. However, in 2025, MDT stock is up 14.8%, surpassing the SPX’s 3.1% rise on a YTD basis.